These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 7712460
41. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2. Joyce NC, Harris DL, Mello DM. Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410 [Abstract] [Full Text] [Related]
49. The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia. Faderl S, Estrov Z, Kantarjian HM, Thomas D, Cortes J, Manshouri T, Chan CC, Hays KJ, Pierce S, Albitar M. Cytokines Cell Mol Ther; 1999 Sep 01; 5(3):159-63. PubMed ID: 10641574 [Abstract] [Full Text] [Related]
50. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma. Takita J, Hayashi Y, Kohno T, Yamaguchi N, Hanada R, Yamamoto K, Yokota J. Cancer Res; 1997 Mar 01; 57(5):907-12. PubMed ID: 9041193 [Abstract] [Full Text] [Related]
51. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1. Flørenes VA, Bhattacharya N, Bani MR, Ben-David Y, Kerbel RS, Slingerland JM. Oncogene; 1996 Dec 05; 13(11):2447-57. PubMed ID: 8957087 [Abstract] [Full Text] [Related]
52. Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation. Lois AF, Cooper LT, Geng Y, Nobori T, Carson D. Cancer Res; 1995 Sep 15; 55(18):4010-3. PubMed ID: 7664273 [Abstract] [Full Text] [Related]
53. Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector. Jin X, Nguyen D, Zhang WW, Kyritsis AP, Roth JA. Cancer Res; 1995 Aug 01; 55(15):3250-3. PubMed ID: 7614457 [Abstract] [Full Text] [Related]
55. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus. Walker C, Ahn YT, Everitt J, Yuan X. Mol Carcinog; 1996 Feb 01; 15(2):154-61. PubMed ID: 8599582 [Abstract] [Full Text] [Related]
56. Status and expression of the p16INK4 gene in human thyroid tumors and thyroid-tumor cell lines. Calabrò V, Strazzullo M, La Mantia G, Fedele M, Paulin C, Fusco A, Lania L. Int J Cancer; 1996 Jul 03; 67(1):29-34. PubMed ID: 8690521 [Abstract] [Full Text] [Related]
58. Hereditary renal cell carcinoma in the rat associated with nonrandom loss of chromosomes 5 and 6. Funaki K, Everitt J, Oshimura M, Freed JJ, Knudson AG, Walker C. Cancer Res; 1991 Aug 15; 51(16):4415-22. PubMed ID: 1868463 [Abstract] [Full Text] [Related]
59. Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors. Rodabaugh KJ, Biggs RB, Qureshi JA, Barrett AJ, Welch WR, Bell DA, Berkowitz RS, Mok SC. Oncogene; 1995 Oct 05; 11(7):1249-54. PubMed ID: 7478544 [Abstract] [Full Text] [Related]
60. p16INK4 and p15INK4B alterations in primary gynecologic malignancy. Wong YF, Chung TK, Cheung TH, Nobori T, Yim SF, Lai KW, Phil M, Yu AL, Diccianni MB, Li TZ, Chang AM. Gynecol Oncol; 1997 May 05; 65(2):319-24. PubMed ID: 9159345 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]